{"schema_version":"secwatch.filing_event.v1","accession":"0001503274-26-000035","form_type":"8-K","ticker":"QTRX","cik":"0001503274","company_name":"Quanterix Corp","filed_at":"2026-08-10T12:07:28+00:00","discovered_at":"2026-08-10T12:10:05.343156+00:00","generated_at":"2026-08-10T12:10:30.741406+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Quanterix Q2 revenue $32.9M (+34% YoY) but cuts FY26 outlook to $142-148M; $26.9M goodwill impairment","bullets":["Revenue $32.9M, +34% YoY; adjusted EBITDA loss $10.0M vs $13.7M prior year.","FY26 revenue guidance cut to $142-148M from $169-174M; year-end cash ~$80M vs $100M prior.","$26.9M goodwill impairment on Akoya; completed ERP integration with $85M annualized savings.","Jim Gute named CCO; other exec appointments (Albrecht, Catalano, Faessler).","Anthem BCBS coverage for Lucent AD Complete starting July 1, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001503274-26-000035","json":"https://secwatch.observer/filing/0001503274-26-000035.json","markdown":"https://secwatch.observer/filing/0001503274-26-000035.md","text":"https://secwatch.observer/filing/0001503274-26-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1503274/000150327426000035/0001503274-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1503274/000150327426000035/qtrx-20260810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T12:10:30.741406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}